ArticleJAAD case reports2026

Immune checkpoint inhibitor-associated scleroderma refractory to corticosteroids: Clinical improvement with intravenous immune globulin and dupilumab.

Dema G Abul-Enin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.